Stay updated on Pembrolizumab Combo in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in mCRPC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.4.2 is now displayed, replacing the former v3.4.1. This update does not modify the study content or how users interact with the page.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page. This is a minor version update and does not affect study content, eligibility criteria, outcomes, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check34 days agoChange DetectedUI and text updates include adding a glossary toggle (Show/Hide glossary), adjusting the QC criterion label from previous wording to a new one, and adding 'No FEAR Act Data' and 'Revision: v3.4.0' notes. These changes do not affect the study content or critical study information.SummaryDifference0.1%

- Check41 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check69 days agoChange DetectedThe Locations section was updated with a large number of new trial sites across multiple countries (US, Canada, Europe, Asia, Australia, and South America), expanding where patients may enroll. At the same time, many existing locations were removed, indicating a restructuring of site availability.SummaryDifference4%

- Check90 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. This appears to be a minor backend/UI update and does not change the study content or results.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.